RehabCare Group commences public offering of 4,350,000 shares of its common stock

NewsGuard 100/100 Score

RehabCare Group, Inc. (NYSE: RHB) announced today it has commenced an underwritten public offering of 4,350,000 shares of its common stock pursuant to the Company’s shelf registration statement filed with the Securities and Exchange Commission (the “SEC”). The underwriters will have a 30-day option to purchase an additional 652,500 shares of common stock from the Company at the public offering price, less underwriting discounts and commissions, solely to cover over-allotments, if any.

The Company intends to use the net proceeds from the offering, together with borrowings under the Company’s new senior credit facilities and cash on hand, to pay the consideration of its acquisition of Triumph HealthCare and related fees and expenses. Any proceeds from the offering in excess of amounts needed to pay the acquisition consideration and related fees and expenses will be used for general corporate purposes. If the acquisition is not consummated, the Company expects to use the net proceeds of the offering for general corporate purposes.

BofA Merrill Lynch and J.P. Morgan Securities Inc. are serving as joint book-running managers for the offering, and Deutsche Bank Securities, RBC Capital Markets and Morgan Keegan & Company, Inc. are serving as co-managers.

Source:

RehabCare Group, Inc.

Posted in:

Tags: , ,

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.